← 홈

VEGF

241개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 241개
AntibodystaleRochePhase 2

Bevacizumab and Bortezomib (Bevacizumab and Bortezomib)

Renal Cell Cancer · Renal Cell Cancer

#RenalCellCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab and Carboplatin (Bevacizumab and Carboplatin)

Glioblastoma Multiforme; Anaplastic Astrocytoma · Glioblastoma Multiforme

#GlioblastomaMultiforme#Antibody#Phase2#항체#면역항체+3
효능 ORR 49.3%임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

Bevacizumab and Erlotinib (Bevacizumab and Erlotinib)

Cancer · Cancer

#Cancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 24%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

Bevacizumab and Sunitinib (Bevacizumab and Sunitinib)

Metastatic Renal Cell Carcinoma; Kidney Cancer · Metastatic Renal Cell Carcinoma

#MetastaticRenalCellCarcinoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab and Temozolomide and radiotherapy (Bevacizumab and Temozolomide and radiotherapy)

Glioblastoma Multiforme · Glioblastoma Multiforme

#GlioblastomaMultiforme#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Bevacizumab and trastuzumab maintenance therapy)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

BEVZ92 (Bevacizumab biosimilar, Bevacizumab biosimilar (BEVZ92))

Metastatic Colorectal Cancer (mCRC) · Metastatic Colorectal Cancer (mCRC)

#MetastaticColorectalCancermCRC#Antibody#Phase1#항체#면역항체+2
효능 ORR 46.4%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab combined with Sintilimab (Bevacizumab combined with Sintilimab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

Bevacizumab control (Bevacizumab control)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

Bevacizumab cycles 3 onwards (Bevacizumab cycles 3 onwards)

Colorectal Carcinoma; Liver Metastases · Colorectal Carcinoma

#ColorectalCarcinoma#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Bevacizumab experimental (Bevacizumab experimental)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Bevacizumab maintenance therapy (Bevacizumab maintenance therapy)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

atezolizumab (Tecentriq, Bevacizumab plus Atezolizumab)

Hepatocellular Carcinoma Non-resectable · Hepatocellular Carcinoma Non-resectable

#HepatocellularCarcinomaNon-resec#Antibody#Preclinical#항체#면역항체+2
효능 ORR 49.3%임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Bevacizumab plus erlotinib (Bevacizumab plus erlotinib)

Carcinoma, Non-Small-Cell Lung; Brain Neoplasms · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab (Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab)

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab+Toripalimab+gemcitabine, adjuvant with Toripalimab (Bevacizumab+Toripalimab+gemcitabine, adjuvant with Toripalimab)

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

Bevacizumab, CA4P (Bevacizumab, CA4P)

Central Nervous System Tumors · Central Nervous System Tumors

#CentralNervousSystemTumors#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 1

Bevacizumab, Everolimus and LBH589 (Bevacizumab, Everolimus and LBH589)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

Bevacizumab, Gemcitabine, Docetaxel and Valproic Acid (Bevacizumab, Gemcitabine, Docetaxel and Valproic Acid)

Sarcoma; Soft Tissue Sarcoma · Sarcoma

#Sarcoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab, Irinotecan and Temozolomide (Bevacizumab, Irinotecan and Temozolomide)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

4 / 13 페이지

← 이전다음 →